Cagrilintide treatment: find your bearings
Use this guide to make sense of care in everyday words. Start with what is available, then take the next question at your own pace.
As of September 28, 2026, neither cagrilintide nor CagriSema had approval from the US Food and Drug Administration (FDA).
Is this a treatment you can get?
FDA stands for Food and Drug Administration; this US agency reviews medicines.
Cagrilintide is being studied for weight loss; CagriSema combines it with semaglutide (Wegovy, Ozempic).
When checked on September 26, 2026, FDA's position was that federal law does not allow pharmacy compounding with cagrilintide.Read FDA's explanation
Compounding means making a medicine to order.
That word on an offer does not settle the question of access.
Understand the access questionYou can still have a useful care visit
Begin with what you want help with: weight, hunger, or an offer that has left you unsure. Ask a doctor or another health professional who provides treatment to talk through the choices that fit your health.
You can come to a visit without having chosen a drug. A useful opening is: What options can we discuss, and what would make each one a good or poor fit?
Prepare for the conversationFind the question you came with
Start with the question closest to yours.
- What it isThe drug, the hormone, and the combination.
- Can you get it?The dated record for approval and access.
- Study resultsWho was studied, what changed, and what is unknown.
- Side effectsWhat study reports found, and where the gaps remain.
- Care choicesAn approved option and the tradeoffs to discuss.
- Ways to meetOnline or in person, with room for questions.
- Check an offerPublic records and the limits of badges and codes.
- Prepare a visitYour goal, your health details, and a clear next step.
- CostMedicine prices, care fees, and coverage questions.
- QuestionsA list to bring into the conversation.
- Word helpThe terms you may hear, in everyday language.